COVID-19
-
March 14, 2022
Microbiome reflects COVID-19 severity
Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered. -
March 10, 2022
Technique hastens COVID-19 antibody discovery
Optimization of a technique developed at Vanderbilt University Medical Center enables rapid and efficient identification of neutralizing monoclonal antibodies against the virus that causes COVID-19. -
March 7, 2022
Teen shares his battle with MIS-C following COVID-19 infection
Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection. -
March 3, 2022
COVID-19: two years of challenges, lessons, victories
Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee. -
February 25, 2022
Study shows young, healthy adults died from COVID-19 due to ECMO shortage
Vanderbilt research found that nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 17, 2022
Pandemic leads to broader use of monoclonal antibodies
Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.